EIF3A and cancer: Our previous studies found that eIF3a increased the efficacy of cisplatin, anthracycline, and ionizing radiation, the well-known inducers of oxidative stress in cancers, by DNA damage repair (Yin et al., 2011b; Tumia et al., 2020; Chen J et al., 2021).